Biocurious: Forgotten trans-Tasman 'small Big Pharma' takes on the big boys with a niche strategy
2 Articles
2 Articles
Qantas increases trans-Tasman flights by up to 20% for 2025/26 summer peak
Qantas has announced the launch of additional flights between Australia and New Zealand for the southern hemisphere summer peak, with the airline boosting capacity across the Tasman Sea by up to 20% throughout December 2025 and January 2026. According to the airline, the additional flights will “provide more options and greater choice for customers travelling between the two countries during the peak summer holiday period, with around 60,000 add…
Biocurious: Forgotten trans-Tasman 'small Big Pharma' takes on the big boys with a niche strategy
AFT Pharmaceuticals has zeroed in on multiple diseases the big pharma plays don’t bother with – but can be highly profitable AFT has targeted boosting its revenue from NZ$200 million to NZ$300 million within the next two years Some AFT investors are tetchy about substandard returns, but co-founder Hartley Atkinson insists the company is focused on long-term growth When Dr Hartley Atkinson and his nurse wife Marree founded AFT Pharmaceuticals (…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage